David Burdge is the Director Cell & Gene Therapy for CPC Biopharma. David has 12+ years in technical expertise including design, manufacturing, operations, new product introduction and automation within the biopharma and cell/gene therapy processing industries. His background outside of CPC includes research at the University of Minnesota’s Microbial and Plant Genomics Institute where he worked with bioreactors culturing recombinant microbes modified with transposon and Crispr gene editing techniques.